![Ivan Bergstein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ivan Bergstein
Algemeen Directeur bij
STEMLINE THERAPEUTICS, INC.
Profiel
Ivan Bergstein is the founder of Stemline Therapeutics, Inc. (2003) as President & Chief Executive Officer.
Current job is at Lirum Therapeutics, Inc. as Chairman since 2021.
Former jobs include Medical Director at Keryx Biopharmaceuticals, Inc., Medical Director at ACCESS Oncology, Inc., and Senior Biopharmaceuticals Analyst at Nitron Advisors.
Education includes an undergraduate degree from the University of Pennsylvania and a doctorate from Icahn School of Medicine at Mount Sinai.
Actieve functies van Ivan Bergstein
| Bedrijven | Functie | Begin |
|---|---|---|
| STEMLINE THERAPEUTICS, INC. | Algemeen Directeur | - |
| LIRUM THERAPEUTICS, INC. | Voorzitter | 01-11-2021 |
Eerdere bekende functies van Ivan Bergstein
| Bedrijven | Functie | Einde |
|---|---|---|
Nitron Advisors
 Nitron Advisors Investment ManagersFinance Operates investment research company | Corporate Officer/Principal | - |
| KERYX BIOPHARMACEUTICALS | Hoofd Techniek/Wetenschap/O&O | - |
ACCESS Oncology, Inc.
 ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical drugs | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Ivan Bergstein
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
27
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
ACCESS Oncology, Inc.
ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical drugs | Health Technology |
Stemline Therapeutics, Inc.
 Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Icahn School of Medicine at Mount Sinai
 Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nitron Advisors
Nitron Advisors Investment ManagersFinance Operates investment research company | Finance |
Lirum Therapeutics, Inc.
 Lirum Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that focuses on the treatment of debilitating diseases | Health Technology |
